Litcius/Paper detail

Glue-based KRAS inhibitors make their debut cancer trial mark

Asher Mullard

2023Nature Reviews Drug Discovery16 citationsDOI

Topics & Concepts

KRASCancerGLUEMedicineCancer drugsOncologyInternal medicineEngineeringColorectal cancerMechanical engineeringClick Chemistry and ApplicationsPeptidase Inhibition and AnalysisProtease and Inhibitor Mechanisms
Glue-based KRAS inhibitors make their debut cancer trial mark | Litcius